P
BIO icon

Pitcairn’s Bio-Rad Laboratories Class A BIO Stock Holding History

Pitcairn’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-520
Closed -$393K – 612
2021
Q4 		$393K Sell
520
-121
-19% -$90.6K 0.03% 433
2021
Q3 		$478K Sell
641
-455
-42% -$341K 0.03% 362
2021
Q2 		$706K Sell
1,096
-738
-40% -$449K 0.05% 261
2021
Q1 		$1.05M Buy
1,834
+160
+10% +$94.8K 0.07% 191
2020
Q4 		$976K Buy
1,674
+151
+10% +$86K 0.07% 185
2020
Q3 		$785K Buy
1,523
+1,076
+241% +$545K 0.07% 189
2020
Q2 		$202K Buy
+447
New +$197K 0.02% 469

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return